Chase Nielsen

Chase studied Applied Statistics & Analytics at BYU and began his investing career as a Quant Analyst at the BYU Silver Fund, where he built the analytical foundation that shapes his diligence work today.

He has helped raise more than $11M for pre-seed companies and sourced Eradivir at the pre-seed stage, where he serves as a board observer; the company has since scaled in valuation from $15M to more than $1B.

At Ollin Ventures, Chase is a Senior Associate supporting sourcing, diligence, and portfolio work across the firm's early-stage investments.